43
Views
12
CrossRef citations to date
0
Altmetric
Review

Current progress towards the development of tyrosine kinase inhibitors as anticancer agents

Pages 279-292 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Tomi Sawyer, Brendan Boyce, David Dalgarno & John Iuliucci. (2001) Src inhibitors: genomics to therapeutics. Expert Opinion on Investigational Drugs 10:7, pages 1327-1344.
Read now
Jacques Dumas. (2001) Protein kinase inhibitors: emerging pharmacophores 1997 - 2000. Expert Opinion on Therapeutic Patents 11:3, pages 405-429.
Read now
Sandra E Wilkinson & William Harris. (2000) Selective tyrosine kinase inhibitors. Emerging Drugs 5:3, pages 287-297.
Read now
Peter Traxler. (1998) Tyrosine kinase inhibitors in cancer treatment (Part II). Expert Opinion on Therapeutic Patents 8:12, pages 1599-1625.
Read now

Articles from other publishers (8)

Lalhruaizela, Devanshi Patel, Brilliant N. Marak, Jayanta Dowarah, Balkaran Singh Sran, Umesh Chand Singh Yadav & Ved Prakash Singh. (2022) Supramolecular architectures in dihydropyridones: Synthesis, crystal structure, Hirshfeld analysis, cytotoxicity and in silico studies. Journal of Molecular Structure 1250, pages 131671.
Crossref
E. Lukevics, D. Jansone, L. Leite, J. Popelis, G. Andreeva, I. Shestakova, I. Domracheva, V. Bridane & I. Kanepe. (2010) Synthesis and cytotoxicity of phenyl-vinyl derivatives of 4,6,6-trimethyl-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitrile. Chemistry of Heterocyclic Compounds 45:10, pages 1226-1234.
Crossref
Anjali Pandey, Deborah L. Volkots, Joseph M. Seroogy, Jack W. Rose, Jin-Chen Yu, Joseph L. Lambing, Athiwat Hutchaleelaha, Stanley J. Hollenbach, Keith Abe, Neill A. Giese & Robert M. Scarborough. (2002) Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family. Journal of Medicinal Chemistry 45:17, pages 3772-3793.
Crossref
Peter Traxler, Guido Bold, Elisabeth Buchdunger, Giorgio Caravatti, Pascal Furet, Paul Manley, Terence O'Reilly, Jeanette Wood & Juerg Zimmermann. (2001) Tyrosine kinase inhibitors: From rational design to clinical trials. Medicinal Research Reviews 21:6, pages 499-512.
Crossref
Alex Matter. (2001) Tumor angiogenesis as a therapeutic target. Drug Discovery Today 6:19, pages 1005-1024.
Crossref
Dean B. Evans, Peter Traxler & Carlos García-Echeverría. 2000. New Approaches to Drug Development. New Approaches to Drug Development 123 139 .
Carlos Garc�a-Echeverr�a, Peter Traxler & Dean B. Evans. (2000) ATP site-directed competitive and irreversible inhibitors of protein kinases. Medicinal Research Reviews 20:1, pages 28-57.
Crossref
James M Hamby & H.D.Hollis Showalter. (1999) Small Molecule Inhibitors of Tumor-Promoted Angiogenesis, Including Protein Tyrosine Kinase Inhibitors. Pharmacology & Therapeutics 82:2-3, pages 169-193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.